203 related articles for article (PubMed ID: 1346236)
1. Neu proto-oncogene amplification and expression in ovarian adenocarcinoma cell lines.
King BL; Carter D; Foellmer HG; Kacinski BM
Am J Pathol; 1992 Jan; 140(1):23-31. PubMed ID: 1346236
[TBL] [Abstract][Full Text] [Related]
2. Enhanced c-erbB-2/neu expression in human ovarian cancer cells correlates with more severe malignancy that can be suppressed by E1A.
Yu D; Wolf JK; Scanlon M; Price JE; Hung MC
Cancer Res; 1993 Feb; 53(4):891-8. PubMed ID: 8094034
[TBL] [Abstract][Full Text] [Related]
3. Aberrant expression of the c-erbB-2/neu protooncogene in ovarian cancer.
Hung MC; Zhang X; Yan DH; Zhang HZ; He GP; Zhang TQ; Shi DR
Cancer Lett; 1992 Jan; 61(2):95-103. PubMed ID: 1346099
[TBL] [Abstract][Full Text] [Related]
4. Determination of HER-2/neu amplification and expression in tumor tissue and cultured cells using a simple, phenol free method for nucleic acid isolation.
Kury FD; Schneeberger C; Sliutz G; Kubista E; Salzer H; Medl M; Leodolter S; Swoboda H; Zeillinger R; Spona J
Oncogene; 1990 Sep; 5(9):1403-8. PubMed ID: 1699198
[TBL] [Abstract][Full Text] [Related]
5. NEU protein overexpression in benign, borderline, and malignant ovarian neoplasms.
Kacinski BM; Mayer AG; King BL; Carter D; Chambers SK
Gynecol Oncol; 1992 Mar; 44(3):245-53. PubMed ID: 1347282
[TBL] [Abstract][Full Text] [Related]
6. Steroid hormonal independence of HER-2/neu mRNA expression in four human ovarian carcinoma cell lines.
Jones J; Lagasse LD; Karlan BY
Gynecol Oncol; 1994 Dec; 55(3 Pt 1):421-6. PubMed ID: 7835782
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of p185 is not related to erbB2 amplification in ovarian cancer.
Morali F; Cattabeni M; Tagliabue E; Campiglio M; Menard S; Marzola M; Lucchini V; Colombo N; Mangioni C; Redaelli L
Ann Oncol; 1993 Nov; 4(9):775-9. PubMed ID: 7904177
[TBL] [Abstract][Full Text] [Related]
8. HER-2/neu oncogene characterization in head and neck squamous cell carcinoma.
Beckhardt RN; Kiyokawa N; Xi L; Liu TJ; Hung MC; el-Naggar AK; Zhang HZ; Clayman GL
Arch Otolaryngol Head Neck Surg; 1995 Nov; 121(11):1265-70. PubMed ID: 7576473
[TBL] [Abstract][Full Text] [Related]
9. Resistance of human ovarian cancer cells to tumor necrosis factor and lymphokine-activated killer cells: correlation with expression of HER2/neu oncogenes.
Lichtenstein A; Berenson J; Gera JF; Waldburger K; Martinez-Maza O; Berek JS
Cancer Res; 1990 Nov; 50(22):7364-70. PubMed ID: 1977519
[TBL] [Abstract][Full Text] [Related]
10. Phosphatidylinositol 3-kinase recruitment by p185erbB-2 and erbB-3 is potently induced by neu differentiation factor/heregulin during mitogenesis and is constitutively elevated in growth factor-independent breast carcinoma cells with c-erbB-2 gene amplification.
Ram TG; Ethier SP
Cell Growth Differ; 1996 May; 7(5):551-61. PubMed ID: 8732665
[TBL] [Abstract][Full Text] [Related]
11. Amplification and expression of c-Ki-ras oncogene in human ovarian cancer.
Chien CH; Chang KT; Chow SN
Proc Natl Sci Counc Repub China B; 1990 Jan; 14(1):27-32. PubMed ID: 1696386
[TBL] [Abstract][Full Text] [Related]
12. Integrin-linked kinase expression increases with ovarian tumour grade and is sustained by peritoneal tumour fluid.
Ahmed N; Riley C; Oliva K; Stutt E; Rice GE; Quinn MA
J Pathol; 2003 Oct; 201(2):229-37. PubMed ID: 14517840
[TBL] [Abstract][Full Text] [Related]
13. In vivo cytotoxicity of ovarian cancer cells through tumor-selective expression of the BAX gene.
Tai YT; Strobel T; Kufe D; Cannistra SA
Cancer Res; 1999 May; 59(9):2121-6. PubMed ID: 10232598
[TBL] [Abstract][Full Text] [Related]
14. ERBB2 amplifications in esophageal adenocarcinoma.
Dahlberg PS; Jacobson BA; Dahal G; Fink JM; Kratzke RA; Maddaus MA; Ferrin LJ
Ann Thorac Surg; 2004 Nov; 78(5):1790-800. PubMed ID: 15511476
[TBL] [Abstract][Full Text] [Related]
15. Her-2/neu expression in node-negative breast cancer: direct tissue quantitation by computerized image analysis and association of overexpression with increased risk of recurrent disease.
Press MF; Pike MC; Chazin VR; Hung G; Udove JA; Markowicz M; Danyluk J; Godolphin W; Sliwkowski M; Akita R
Cancer Res; 1993 Oct; 53(20):4960-70. PubMed ID: 8104689
[TBL] [Abstract][Full Text] [Related]
16. Increased expression of specific protein tyrosine phosphatases in human breast epithelial cells neoplastically transformed by the neu oncogene.
Zhai YF; Beittenmiller H; Wang B; Gould MN; Oakley C; Esselman WJ; Welsch CW
Cancer Res; 1993 May; 53(10 Suppl):2272-8. PubMed ID: 8097963
[TBL] [Abstract][Full Text] [Related]
17. Expression of c-erb B-2/neu proto-oncogene in human prostatic cancer tissues and cell lines.
Zhau HE; Wan DS; Zhou J; Miller GJ; von Eschenbach AC
Mol Carcinog; 1992; 5(4):320-7. PubMed ID: 1353965
[TBL] [Abstract][Full Text] [Related]
18. HER-2/neu oncogene amplification by fluorescence in situ hybridization in epithelial tumors of the ovary.
Ross JS; Yang F; Kallakury BV; Sheehan CE; Ambros RA; Muraca PJ
Am J Clin Pathol; 1999 Mar; 111(3):311-6. PubMed ID: 10078105
[TBL] [Abstract][Full Text] [Related]
19. Expression and amplification of the HER-2/neu (c-erbB-2) protooncogene in epithelial ovarian tumors and cell lines.
Tyson FL; Boyer CM; Kaufman R; O'Briant K; Cram G; Crews JR; Soper JT; Daly L; Fowler WC; Haskill JS
Am J Obstet Gynecol; 1991 Sep; 165(3):640-6. PubMed ID: 1679963
[TBL] [Abstract][Full Text] [Related]
20. Antibody to HER-2/neu receptor blocks DNA repair after cisplatin in human breast and ovarian cancer cells.
Pietras RJ; Fendly BM; Chazin VR; Pegram MD; Howell SB; Slamon DJ
Oncogene; 1994 Jul; 9(7):1829-38. PubMed ID: 7911565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]